Patient Guide: A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06984718
Status: NOT_YET_RECRUITING
Condition: HCC, Hepatocellular Carcinoma
Phase: PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily